Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(29%)
Results Posted
100%(3 trials)

Phase Distribution

Ph phase_1
1
14%
Ph phase_3
2
29%
Ph phase_2
4
57%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Other(2)

Detailed Status

Completed3
Active, not recruiting2
Suspended1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 24 (57.1%)
Phase 32 (28.6%)

Trials by Status

suspended114%
unknown114%
completed343%
active_not_recruiting229%

Recent Activity

2 active trials
Showing 5 of 7
active_not_recruitingphase_2

Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

NCT05690503
suspendedphase_3

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

NCT03344419
active_not_recruitingphase_3

Facilitating Rapid Naltrexone Initiation

NCT03345173
unknownphase_2

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

NCT04084860
completedphase_1

Facilitating the Behavioral Treatment of Cannabis Use Disorder

NCT02946489
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05690503Phase 2

Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

Active Not Recruiting
NCT03344419Phase 3

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

Suspended
NCT03345173Phase 3

Facilitating Rapid Naltrexone Initiation

Active Not Recruiting
NCT04084860Phase 2

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

Unknown
NCT02946489Phase 1

Facilitating the Behavioral Treatment of Cannabis Use Disorder

Completed
NCT02539511Phase 2

Glutamatergic Modulation of Disordered Alcohol Use

Completed
NCT02596022Phase 2

The Effect of Glutamatergic Modulation on Cocaine Self-administration

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7